Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid,...
Q2 2026
Aug 5, 2026
Q1 2026
May 6, 2026
FY 2025
Feb 26, 2026
Q4 2025
Q3 2025
Nov 6, 2025